Qiming U.S. Ventures Management as of March 31, 2023
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 7 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ventyx Biosciences (VTYX) | 30.3 | $25M | 746k | 33.50 | |
| Icosavax | 24.6 | $20M | 3.5M | 5.80 | |
| Jasper Therapeutics | 18.7 | $15M | 8.5M | 1.81 | |
| Hillevax (HLVX) | 11.2 | $9.2M | 559k | 16.53 | |
| Talaris Therapeutics | 6.7 | $5.5M | 2.9M | 1.88 | |
| Elevation Oncology (ELEV) | 5.4 | $4.5M | 2.4M | 1.90 | |
| Kezar Life Sciences (KZR) | 3.1 | $2.6M | 829k | 3.13 |
